Assura PLC Scrip Dividend Declaration (7599K)
July 17 2017 - 2:00AM
UK Regulatory
TIDMAGR
RNS Number : 7599K
Assura PLC
17 July 2017
17 July 2017
Assura plc
Scrip Dividend Declaration
Assura plc ("Assura" or "the Company"), the UK's leading primary
care property investor and developer, today announces that,
pursuant to its Scrip Dividend Scheme and in response to the scrip
dividend alternative for the quarterly interim dividend payable on
19 July 2017 (the "Scrip Dividend Alternative"), elections were
received in respect of 24 per cent. of the Company's ordinary
shares in issue as at the record date of 16 June 2017.
Electing shareholders will receive ordinary shares in the
Company ("Shares") in lieu of cash in respect of this dividend and,
accordingly 3,861,017 Shares (the "New Shares") will be issued by
the Company to such shareholders.
Application has therefore been made for the admission of the New
Shares to the Official List of the UK Listing Authority and to
trading on the London Stock Exchange's market for listed securities
("Admission"). The New Shares will rank pari passu with the
Company's existing ordinary shares and Admission is expected to
occur at 8.00am on 19 July 2017.
Following the allotment of the New Shares, it is expected that
the total number of shares in issue will be 1,824,416,077 (none of
which will be held in treasury) and that, accordingly, the total
number of voting rights of the Company will be 1,824,416,077.
Copies of the documents relating to the Scrip Dividend
Alternative are available for inspection through the National
Storage Mechanism (http://www.morningstar.co.uk/uk/NSM).
No Property Income Distribution ("PID") is included in this
interim dividend. However, forms to register for gross PIDs (when
these become payable) are available on the Company's website.
Please click here for PID Forms.
-ENDS-
Enquiries
Assura plc Tel: 01925 420660
Orla Ball
Finsbury Tel: 0207 251 3801
Gordon Simpson
Notes to Editors
Assura plc, a constituent of the FTSE 250 and the EPRA* indices,
is a UK REIT and long-term investor in and developer of primary
care property. The company, headquartered in Warrington, works with
GPs, health professionals and the NHS to create innovative property
solutions in order to facilitate delivery of high quality patient
care in the community. At 31 March 2017, Assura's property
portfolio was valued at GBP1,345 million.
Further information is available at www.assuraplc.com
*EPRA is a registered trademark of the European Public Real
Estate Association
This information is provided by RNS
The company news service from the London Stock Exchange
END
DIVBSGDRUSBBGRB
(END) Dow Jones Newswires
July 17, 2017 02:00 ET (06:00 GMT)
Assura (LSE:AGR)
Historical Stock Chart
From Aug 2024 to Sep 2024
Assura (LSE:AGR)
Historical Stock Chart
From Sep 2023 to Sep 2024